
IHC Q4 Results 2025: Net Profit Surges 30.40% YoY; Share Price Fell Over 6%
Updated: 6 May 2025 • 5:16 pm
Posted by:

IHC, or Indian Hotels Company, announced its Q4 results for FY25. In the financial reports, the company declared a 30.40% YoY surge in standalone net profit, reaching ₹481.20 crore. The IHCL share is currently trading at ₹750.95 per share with a 6.34% decline. Scroll down to explore key highlights from IHC Q4 results FY25.
IHC Q4 Results 2025: Key Highlights
- IHC reported a 30.40% YoY surge in net profit, rising from ₹369.08 crore to ₹468.77 crore in the fourth quarter of FY25.
- Standalone revenue from operations of Indian Hotels Company stood at ₹1,476.33 crore, up 10% year over year from ₹1,341.65 crore in the corresponding quarter of the previous year.
- Consolidated net profit of IHC increased by 27% YoY to reach ₹522.30 crore in Q4FY25.
- The consolidated EBITDA jumped 30% to ₹856.60 crore, with the margin improving to 35.30% from 34.60% of the previous year.
IHC Share: Dividend Declaration
Indian Hotel Company has recommended a dividend of ₹2.25 per share. However, the dividend is subject to the approval of shareholders in the forthcoming annual general meeting.
IHC Management Investment Plans
India Hotels Company announced its 12th consecutive quarter of impeccable financial performance, representing robust operational momentum. IHCL has specified a budget of more than ₹1,200 crore for investments in asset upgradations, management initiatives, and new developments. As of now, IHC has a portfolio of 380 hotels, comprising 45,994 rooms, with 243 operational hotels comprising 26,494 rooms.
IHCL Share Performance
The IHCL share price is currently trading at ₹750.95 per share with a fall of 6.34%. Moreover, the stock has delivered 1,051.59% returns in the past 5 years and proved to be one of the multibagger stocks. The 52-week high/low of the IHCL share is marked as ₹894.90/₹506.45.
Final Thoughts
IHC or Indian Hotels Company reported a 30.40% YoY increase in its standalone net profit for the fourth quarter of FY25. Despite surge in financial figures, IHCL share price fell over 6% today on 6th May 2025.
For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent News Articles
BPCL Q4 Results 2025 Declared: Share Price Surges 6%
Stock Market Today: Sensex Fell 260 Points & Nifty50 By 0.41%; Check Key Insights
DMART Q4 Results 2025: Net Profit Declined 2% to ₹551 Crore; Check Key Highlights
Stocks to Watch Today: 6th May 2025 | GAIL, Glenmark, Yes Bank, DCM Shriram, ONGC, & More!
Other News Articles
Kotak Mahindra Bank Q4 Results 2025: Net Profit Down 14%; Share Plunges Over 5%
Marico Q4 Results 2025 Highlights: PAT Up 8% & Dividend of ₹7 Declared; Check Key Insights
Manoj Jewellers IPO GMP: Day 1 IPO Live Updates
Railtel Q4 Results 2025: Net Profit Surges 46.30% On Robust Operational Gains | Check Insights
Srigee DLM IPO GMP: Day 1 IPO Live Updates
Stocks to Watch Today: 5th May 2025 | IGL, Ircon, Tata Motors, NTPC, NMDC, & More!
Recent Articles

Dalmia Industrial Development Q4 FY26 Results: PAT Rs 0.01 Cr, Revenue Rs 0.50 Crore
19 May 2026

Ideal Technoplast Industries Q4 FY26 Results: PAT Rs 1.00 Cr, Revenue Rs 8.00 Crore
19 May 2026

Goldline Pharmaceutical Share Price Locked in 5% Lower Circuit After Bumper BSE SME Debut: Rs 59.87 Open, Rs 56.66 Circuit — What Happened and What Next
19 May 2026

Goel Construction Company Q4 FY26 Results: PAT Rs 11 Cr, Revenue Rs 159 Crore
19 May 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Recent Posts
Dalmia Industrial Development Q4 FY26 Results: PAT Rs 0.01 Cr, Revenue Rs 0.50 Crore
Ideal Technoplast Industries Q4 FY26 Results: PAT Rs 1.00 Cr, Revenue Rs 8.00 Crore
Goldline Pharmaceutical Share Price Locked in 5% Lower Circuit After Bumper BSE SME Debut: Rs 59.87 Open, Rs 56.66 Circuit — What Happened and What Next
Goel Construction Company Q4 FY26 Results: PAT Rs 11 Cr, Revenue Rs 159 Crore
Arvee Laboratories (India) Q4 FY26 Results: PAT Rs 0.50 Cr, Revenue Rs 9.00 Crore
Popular this week
Dalmia Industrial Development Q4 FY26 Results: PAT Rs 0.01 Cr, Revenue Rs 0.50 Crore
Ideal Technoplast Industries Q4 FY26 Results: PAT Rs 1.00 Cr, Revenue Rs 8.00 Crore
Goldline Pharmaceutical Share Price Locked in 5% Lower Circuit After Bumper BSE SME Debut: Rs 59.87 Open, Rs 56.66 Circuit — What Happened and What Next
Goel Construction Company Q4 FY26 Results: PAT Rs 11 Cr, Revenue Rs 159 Crore
Arvee Laboratories (India) Q4 FY26 Results: PAT Rs 0.50 Cr, Revenue Rs 9.00 Crore

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
